X0305 4 2012-03-23 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001532218 Patel Sanj K 128 SPRING STREET, SUITE 520 LEXINGTON MA 02421 true true false false President & CEO Common Stock 2012-03-23 4 M false 50000 0.95 A 51031 D Common Stock 2012-03-23 4 S false 50000 33.5282 D 1031 D Stock Option (Right to Buy) 0.95 2012-03-23 4 M false 50000 0 D 2019-07-01 Common Stock 50000 346070 D The stock option exercise and sale of common stock reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on December 8, 2011. The Stock Option granted the reporting person an option to purchase 396,070 shares of Common Stock (the "Shares"). 25% of the Shares vested and became exercisable on 07/01/2010, and 1/36 of the remainder of the Shares vest and become exercisable monthly thereafter. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $33.50 to $33.96. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price. /s/ Sanj K. Patel 2012-03-27